JRARX
Price
$90.53
Change
-$0.42 (-0.46%)
Updated
Aug 20 closing price
Net Assets
27.73B
RGACX
Price
$80.90
Change
-$0.39 (-0.48%)
Updated
Aug 20 closing price
Net Assets
325.58B
Interact to see
Advertisement

JRARX vs RGACX

Header iconJRARX vs RGACX Comparison
Open Charts JRARX vs RGACXBanner chart's image
Janus Henderson Research R
Price$90.53
Change-$0.42 (-0.46%)
VolumeN/A
Net Assets27.73B
American Funds Growth Fund of Amer R3
Price$80.90
Change-$0.39 (-0.48%)
VolumeN/A
Net Assets325.58B
JRARX vs RGACX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
JRARX vs. RGACX commentary
Aug 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JRARX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 326B vs. JRARX (27.7B). RGACX pays higher dividends than JRARX: RGACX (0.07) vs JRARX (0.00). JRARX was incepted earlier than RGACX: JRARX (9 years) vs RGACX (23 years). JRARX (1.38) is less costly to investors than RGACX (0.94). JRARX is a more actively managed with annual turnover of: 27.00 vs. RGACX (25.00). RGACX has a lower initial minimum investment than JRARX: RGACX (250) vs JRARX (2500). JRARX annual gain was more profitable for investors over the last year : 14.39 vs. RGACX (11.81). JRARX return over 5 years is better than : 53.97 vs. RGACX (38.00).
JRARXRGACXJRARX / RGACX
Total Expense Ratio1.320.94140%
Annual Report Gross Expense Ratio1.380.94147%
Fund Existence9 years23 years-
Gain YTD12.00712.91893%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets27.7B326B8%
Annual Yield % from dividends0.000.07-
Returns for 1 year14.3911.81122%
Returns for 3 years71.8043.79164%
Returns for 5 years53.9738.00142%
Returns for 10 yearsN/A93.80-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AIM2.510.15
+6.36%
AIM ImmunoTech Inc
OMC77.671.51
+1.98%
Omnicom Group
BWIN33.320.63
+1.93%
The Baldwin Insurance Group Inc.
RAPP14.24-0.35
-2.40%
Rapport Therapeutics Inc.
CTM1.02-0.06
-5.56%
Castellum